Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,397 filings

Top spenders & firms Spend by issue

Clear
Q3
COREWELL HEALTH for COREWELL HEALTH
3rd Quarter (July 1 - Sep 30) 2025 · Michigan · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Labor Issues/Antitrust/Workplace
View →
Q3
INDEPENDENT PHARMACY COOPERATIVE for INDEPENDENT PHARMACY COOPERATIVE
3rd Quarter (July 1 - Sep 30) 2025 · Wisconsin · House · Senate
Pharmacy
View →
RR
CHAMBER HILL STRATEGIES for OS THERAPIES
3rd Quarter (July 1 - Sep 30) 2025 · New York
Pharmacy, Health Issues
View →
2A
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
1A
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
Q3
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
2A
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
1A
ELI LILLY AND COMPANY for ELI LILLY AND COMPANY
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Trade (domestic/foreign), Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
Q3
TRAVERE THERAPEUTICS for TRAVERE THERAPEUTICS
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Medical/Disease Research/Clinical Labs, Medicare/Medicaid
View →
Q3
MR. BRIAN KELLY for TAKEDA PHARMACEUTICAL COMPANY
3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $10,000.00 income
Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q3
DESIMONE CONSULTING, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income
Pharmacy
View →
Q3
HEALTHSPERIEN for EXACT CARE PHARMACY
3rd Quarter (July 1 - Sep 30) 2025 · Ohio · House · Senate · $30,000.00 income
Pharmacy, Health Issues
View →
Q3
SAREPTA THERAPEUTICS, INC. for SAREPTA THERAPEUTICS, INC.
3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate
Health Issues, Pharmacy, Science/Technology, Taxation/Internal Revenue Code
View →
Q3
ARNOLD & PORTER KAYE SCHOLER LLP for NOVO NORDISK, INC.
3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $80,000.00 income
Pharmacy, Health Issues, Medicare/Medicaid, Consumer Issues/Safety/Products
View →
3A
TARPLIN, DOWNS & YOUNG, LLC for HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $80,000.00 income
Pharmacy, Health Issues, Budget/Appropriations
View →
Q3
TARPLIN, DOWNS & YOUNG, LLC for HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.)
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate · $80,000.00 income
Pharmacy, Health Issues, Budget/Appropriations
View →
Q3
WALGREEN COMPANY for WALGREEN COMPANY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code
View →
Q3
WALGREEN COMPANY for WALGREEN COMPANY
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code
View →
Q3
CONSUMER HEALTHCARE PRODUCTS ASSOCIATION for CONSUMER HEALTHCARE PRODUCTS ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $254,122.00 income
Health Issues, Pharmacy, Consumer Issues/Safety/Products, Taxation/Internal Revenue Code
View →
Q3
KEEFE SINGISER PARTNERS, FKA KEEFE STRATEGIES LLC for CVS HEALTH
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $30,000.00 income
Health Issues, Pharmacy
View →
Q3
NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION for NATIONAL FAMILY PLANNING AND REPRODUCTIVE HEALTH ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Medicare/Medicaid, Family issues/Abortion/Adoption, Pharmacy
View →
Q3
ERIE FAMILY HEALTH CENTERS for ERIE FAMILY HEALTH CENTERS
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Health Issues, Medicare/Medicaid, Budget/Appropriations, Pharmacy
View →
Q3
VENABLE LLP for MEDISCA INC.
3rd Quarter (July 1 - Sep 30) 2025 · New York · $20,000.00 income
Pharmacy
View →
Q3
KOUNTOUPES DENHAM CARR & REID, LLC for MCKESSON CORPORATION
3rd Quarter (July 1 - Sep 30) 2025 · Texas · House · Senate · $60,000.00 income
Health Issues, Pharmacy
View →
Q3
KOUNTOUPES DENHAM CARR & REID, LLC for CVS HEALTH
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy, Medicare/Medicaid, Insurance, Health Issues
View →
Previous Page 27 of 56 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem